Clinical Trial Update: ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 biomarker-driven trial (ProBio) in metastatic prostate cancer is currently recruiting, enrolling patients with metastatic castration-resistant and metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Hormone-sensitive Prostate Cancer

Snippet

Sponsor: Karolinska Institutet | Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Phase 3 | Status: RECRUITING